MedaSystems, the leading SaaS platform for Expanded Access and Investigator Initiated Trials, is pleased to announce the recent appointment of Brian Irwin as Chief Executive Officer and Board Member. With over 25 years of strategic leadership in Life Science data analytics, SaaS technology, and healthcare investing, Brian joins MedaSystems at a pivotal time, bringing an impressive track record in scaling growth within these sectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241208538445/en/
BRIAN IRWIN Brian is a strategic leader with 25 years of driving exceptional growth as an Operator, Executive, Investor, and Entrepreneur in the Healthcare and Life Sciences industries. His expertise lies in SaaS technology, data and analytics, and pharmaceutical research and development. Before joining MedaSystems as our CEO, Brian was the Chief Growth Officer at Optum Life Sciences. He led the company to increase its annual sales by millions by spearheading market expansion strategies, global mergers and acquisitions, and working closely with UHG’s corporate development team. (Photo: Business Wire)
“I’m thrilled to join MedaSystems at this pivotal moment to advance our mission of accelerating patient access to essential treatments,” said Brian Irwin, CEO of MedaSystems. “Our commitment to transforming legacy manual approaches of expanded access and compassionate use makes us a key partner in driving global improvement for the patient and Health Care Provider experiences with these programs.”
Brian most recently served as Chief Growth Officer at Optum Life Sciences, where he successfully led all market expansion, enterprise partnerships, and key strategic initiatives with United Health Group to drive impressive revenue growth. His experience with large-scale operations and strategic alignment brings valuable insight to MedaSystems as the company continues to expand its impact in improving patient access to investigational therapies.
For over a decade, Brian served as SVP of Strategy, Corporate Development, and Board Observer for SHYFT Analytics, a SaaS data and analytics company also serving the Life Science sector. He played a vital role in SHYFT’s strategic growth and eventual acquisition, focusing on broad industry partnerships, corporate financing, and market expansion. His entrepreneurial approach was further refined at Optum Ventures, where he served as an Entrepreneur-in-Residence, guiding CEOs on investment strategies and conducting due diligence.
“Brian’s vision and expertise in life sciences technology make him the ideal leader to drive MedaSystems’ mission forward,” said Matt Rosen, EVP and Co-Founder of MedaSystems. “His strategic insight will be invaluable as we advance our solutions and expand our footprint within the industry.”
About MedaSystems
Founded in 2021, MedaSystems is at the forefront of advancing healthcare technology. The MedaSystems platform delivers next-generation solutions for life sciences, enabling healthcare providers and pharmaceutical companies to streamline expanded access programs and leverage real-world data insights. Committed to compliance and data-driven decision-making, MedaSystems empowers organizations to enhance patient outcomes through technology.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241208538445/en/